MxT Biotech
PrivateLast Round
Series A
Apr 1, 2022
Total Funding Raised
$4.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MxT Biotech operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in April 2022.
MxT Biotech is a biotechnology company that develops microfluidic platforms for cell engineering and genome editing applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MxT Biotech Comparables
Compare MxT Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellFE | 90% | |
| Avectas | 84% | |
| Kytopen | 82% |
For institutional investors. Book with your work email.
MxT Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2022 | ||||
| Seed | Jun 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MxT Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hyundai Investment Partners | Series A |
| DAYLI Partners | Series A |
| BNK Venture Capital | Series A |
| We Ventures | Series A |
| AJU IB Investment | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 445% MoM, reaching 1.5K.
- Mar 2, 2026
Monthly visitors grew 299% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
MxT Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MxT Biotech's valuation, stock price, and market status.
Is MxT Biotech a public or private company?
MxT Biotech is a private company.
What is the current stock price of MxT Biotech?
MxT Biotech is a private company, so its shares have no public market price. Caplight tracks MxT Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MxT Biotech worth (valuation)?
Valuation information for MxT Biotech is not publicly available.
Can I buy MxT Biotech stock?
MxT Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MxT Biotech's last funding round?
MxT Biotech's most recent funding round was Series A on April 1, 2022.
Who are the main investors in MxT Biotech?
Key investors in MxT Biotech include Hyundai Investment Partners, DAYLI Partners, BNK Venture Capital, We Ventures, AJU IB Investment.
Will MxT Biotech IPO soon?
No public IPO plans have been announced for MxT Biotech.
How can I track MxT Biotech secondary market activity?
Caplight tracks bids, offers, and trades in MxT Biotech's shares on secondary markets.